Who owns ELOXX PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Eloxx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Eloxx Pharmaceuticals stock

Who bought or sold ELOXX PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Armistice Capital 275k $1.3M 100% Sep 2023
 View chart
Silverarc Capital Management 54k $260k 0% Sep 2023
 View chart
Menora Mivtachim Holdings 52k $252k 0% Sep 2023
 View chart
Altshuler Shaham 25k $30k 0% Dec 2023
 View chart
Geode Capital Management 20k $93k -3% Sep 2023
 View chart
Clal Insurance Enterprises Holdings 14k $65k -8% Sep 2023
 View chart
Atom Investors 11k $51k 100% Sep 2023
 View chart
BlackRock 8.9k $43k 0% Sep 2023
 View chart
Tower Research Capital 1.8k $8.8k -26% Sep 2023
 View chart
Morgan Stanley 79.00 $379.997900 0% Sep 2023
 View chart
Meeder Asset Management 15.00 $18.000000 0% Dec 2023
 View chart
Group One Trading 4.00 $19.000000 0% Sep 2023
 View chart

Who sold out of Eloxx Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
American Financial Group Sep 2023 37k $178k
Vanguard Group Sep 2023 21k $100k
Wells Fargo & Company Sep 2023 1.2k $5.6k
Royal Bank of Canada Sep 2023 526.00 $3.0k
UBS Group Sep 2023 291.00 $1.4k